Features
Pandemic and emergence of variants
By Prof Kirthi Tennakone
The behaviour of the coronavirus bears resemblance to a high-speed magnified video of Darwinian evolution. The virus changes in front of our eyes and variants emerge as the fittest that survive. Genome surveillance has succeeded in reading the genetic changes accurately and sees how the genotype expresses as phenotype. Genotype being the chemical-genetic constitution and phenotype, characters as manifested in the environmental background.
Humans have sinisterly arrested the natural evolution of animals and plants; but despite scientific advancements, find it difficult to deal with a fast-evolving virus, science alone cannot resolve a social calamity. Containment of the pandemic would be difficult if our actions lag in relation to the pace of virus evolution.
Mutations: cause of biological evolution
According to Charles Darwin’s theory of evolution, life on earth continues by descent, inheriting parental characters subject to infrequent variations or mutations. After the discovery of DNA, the mechanism of inheritance and mutations was understood.
The genetic material DNA, present in all living cells, is a double-stranded structure composed of bead-like moieties pairs, known as nucleotide bases, denoted by symbols A, T, G and C. The sequence of these entities in a strand encodes genetic information analogous to a four-letter alphabet. Some viruses contain one strand referred to as RNA and encode information in the same way. When the cell or the virus replicate, most of the time, the sequence of nucleotides is copied exactly giving birth to a genetically identical cell or a virus. Rarely, copying errors creep in during replication. For example, the sequence AAGCT may be miscopied as AAGCG. This is a minor change in comparison to the entire genome, nevertheless a genetic change or a mutation. Most mutations will not lead to overriding alterations in the character of an organism. Mutations are often deleterious. Very infrequently, a change in character, owing to a mutation, turns out to be beneficial for the species to survive and procreate.
Mutants fitting the environment survive and proliferate. Paleontological findings provide ample evidence of the evolutionary process, when noticeable changes in living species manifest during, more or less, millennia. In most cellular organisms a mutation, fit to get established, takes place once in a million generations. For that reason, we do not see sporadic changes in the progenies of animals and plants. In the past there had not been significant alterations in genetically transferred characters of wild animals. The leopards we see today are not different from ones that lived during the Anuradhapura period, their hunting capabilities are similar.
The situation is different if a virus invades a population devoid of immunity. Their intrinsically fast mutation and replication rates and sheer numbers, invariably bring forth more adaptable strains in very short periods. Certainly, the same phenomenon occurred during previous epidemics and pandemics. Today it is happening at an escalated level because of high human population density, mobility and unrestrained interference in the environment.
Viruses live on cellular life, constantly interacting and following their evolution, while they themselves evolve.
Unicellular and multicellular and viruses
The first living cells or unicellular microbes seemed to have originated 3.5 billion years ago. A giant step in the advancement of life on earth has been the appearance of multicellular organisms, living systems made of assemblies of cells. A mutation in a unicellular agent around 1.5 billion years ago is believed to have cleared the way for the development of multicellular life. These individual cells, sharing similar DNA, formed colonies. Later colonies subdivided, each expressing genetic instructions differently to create complex animals, with organs performing varying functions. The above developmental pathways, leading to advanced forms of life existing today, took more than one billion years.
Viruses are distinct from cellular forms of life. The latter possesses the capacity to grow and reproduce, deriving energy and essence of structural materials from non-living substances; whereas the former needs to enter a living cell to reproduce. All cellular creatures and viruses replicate, mutate and interact with each other and the external environment and evolve.
The pandemic is just one episode of this universal phenomenon, progressing fast and tracked by humans, the concern now is the threat posed by variants.
Variants of Coronavirus (SARS-CoV-2)
A variant means a mutated version of an organism, distinct from the original in a noticeable deviation of an observable trait. For example, king coconut is a variant of coconut, the distinguishing attribute being the colour of the nut. Apart from the shade of the nut, this particular mutation had turned the tree into a dwarf, very disadvantageous for harvesting sunlight. Unable to compete with other trees, the king coconut would not survive in the wild. Attracted by the colour, humans (in Sri Lanka) have taken care of the variety and propagated it.
In the case of the Coronavirus, the important qualities distinguishing variants are higher infectivity, degree of virulence and resistance to vaccines.
The Coronavirus and other RNA viruses mutate faster than DNA based organisms. Here the probability of a viable mutation per generation (replication) exceeds 10,000 times that of a cellular life form. Furthermore, the generation time of the Coronavirus is a few hours compared to years and months in the case of animals and the total population of viruses in bodies of infected persons, during the time of the pandemics, is many billions times larger than an animal population. Consequently, Coronavirus variants popped up in durations as short as a few months, after the aggravation of the pandemic in late 2020. The longer the pandemic lasts and the greater the intensity, the more variants we encounter.
Since the emergence of COVID-19 in Wuhan, China in December 2019 and its global spread, many variants have appeared in geographically distinct regions and crossed borders. The original version of the virus which triggered the epidemic in Wuhan underwent the mutation D614G altering the spike proteins, making it more contagious. Soon the strain D614G surfaced almost everywhere initiating the pandemic. It is the common ancestor of almost all variants seen today. The World Health Organization and Center for Disease Control, United States, have classified Coronavirus variants into three categories.
Variants of Concern
: They have increased transmissibility, detrimental alteration in epidemiology, enhanced virulence, decrease effectiveness in public health measures or available vaccines and diagnostics. The Alpha variant detected in the United Kingdom, September 2020; Beta in South Africa, May 2020; Gamma in Brazil November 2020; Delta in India October 2020 falls into this category.
Variants of Interest
: These are strains of the Coronavirus genetically distinguished by sequencing with potentialities of higher transmissibility, disease severity, and immunity resistance. They could pose threats in the future and need to be watched. Variants; Eta, Iota, Kappa, Lambda and Mu recently detected in Colombia are classified as variants of interest.
Variants of high consequence
: These are variants that would largely escape known control measures. Fortunately, at the moment, no candidates come under this category.
How Coronavirus variants originate
A variant begins as a mutation of one single virus in an infected person somewhere. It is very unlikely it would enter someone else and cause the disease. The variant requires to breed sufficiently in the individual in whom it was created. Again, in order to procreate and proliferate, it will have to compete with the parent strain, initially dominant in the patient. The variant will succeed in competing if it replicates faster and more effectively invades cells. As expected, all variants of concern possess the above qualities. Similarly, if the mutant had acquired the trait of evading host immunity, it could overshoot the parent strain.
Variants possibly originate and breed in immunosuppressed persons chronically infected with COVID-19. They carry large viral loads for prolonged durations, a pathology conducive to the birth and growth of variants. A wide range of mutants have been detected in such patients.
Characteristics of variants
Variants of concern spread faster in contrast to the parent strain. A pertinent question is, what changes in the virus provide this facility? For the virus to invade the human system, it must attach to a cell in the respiratory tract and transfer genetic material to the interior of the cell. The virus does this with a special protein in the spikes, binding selectively to a receptor in human cells named ACE2. In variants, the chemistry and architecture of the spikes are redesigned to enhance attachment. Thereafter, the migration of the replicating viruses to adjacent cells is also facilitated by the same process. The host antibodies drive the immune response by attacking spikes to suppress their bondage to the receptors. Mutagenic alterations in the spikes also help the variants to escape host immunity.
Most contagious Delta variant
The delta variant first identified in India, October 2020, resulted in an aggressive epidemic there and rapidly diffused. Several mutations in the spike proteins facilitated its fast spread. While retaining the common ancestral mutation D614G, the Delta carries three other mutations named P681R, L452R and D950N. The mutation D614G increases the number of spikes on the viral envelope. Production of higher viral loads in Delta-infected patients is believed to be a character manifested by the P681R mutation. Their respiratory tracts carry 1000 times more virus particles. The L452R mutation seems to protect spikes from antibodies helping immunity evasion. An ability of the Delta variant to attack a wider group of cells probably originates from a trait induced by D950N mutation. Mainly because of the changes in the spike proteins, the Delta variant reproduces faster by cell-to-cell invasion. Consequently, once this brand of Coronavirus enters a susceptible person, the symptoms appear in a shorter period of four to five days, compared to about a week for the alpha variant.
The Delta variant is 60 percent more transmissible than the alpha which stands 50 percent higher than the ancestral strain. A parameter defining the transmissibility of an infectious disease is the average number of cases reproduced by one carrier of the pathogen, the basic reproduction number (R0). An infection reaches epidemic proportions if R0 exceeds unity. When the pandemic originated in China, the value of R0 was about 2.5. The estimated value of R0 for the delta variant is somewhere between six and nine, an enormous increase in transmissibility relative to the previous strains.
Virus variants compete, whenever the Delta entered new territory, it out-competed other strains.
Vaccinations and Delta Variant
Except for a partial immunity evasion of the Delta variant, vaccines are effective against both variants. Vaccines lower the probability of catching the infection, more importantly greatly reduce serious complications and death. Some statistical assessments conclude that breakthrough infections (re-infections) are higher for the Delta variant compared to Alpha.
The discrepancies reported could also be indications of the fact that the Delta variant is far more contagious than previous strains. Here, the statistically meaningful epidemiological parameters are the number of different categories of infected persons (vaccinated, the severity of infection as determined by hospitalizations and mortality) as a percentage of the total number of infected individuals, recorded temporally. It is extremely difficult to keep track of these quantities when the disease spreads fast. Even the total number of people infected cannot be ascertained reliably. Under such circumstances, the anomalies reported as lesser effectiveness of vaccines in the case of the Delta variant, could also entail errors in data interpretation, arising from the fact that the Delta variant spreads fast.
There are also reports to the effect that more unvaccinated younger adults and children are hospitalized after the arrival of the Delta variant, reflecting the severity of symptoms. Theories have been put forward to explain the apparent anomaly. However, because of faster transmission of the Delta variant, proportionately younger patients may seek hospitalization.
As the dominant strain infecting a large proportion of people; the Delta variant will continue to mutate and evolve. Few mutational changes have already been noticed and named Delta pluses, but there is no evidence to conclude they are more dangerous.
Doomsday variant
News spreads like viruses. Just as mutations, inadvertent or deliberate distortions and exaggerations happen in reproducing news. Versions with more sensational twists disseminate faster.
In May 2021 a new variant carrying mutations suggestive of fast transmission and immunity resistance was identified in South Africa. Months later a reputed epidemiologist tweeted that the variant could be an imminent danger, prompting media to name it a doomsday variant. The ensuing panic was the result of premature unconfirmed assertion. The World Health Organization announced that this variant is not propagating as fast as the Delta.
Stories of pathogens spreading exceedingly fast, evading immunity, are common in science fiction. There is no evidence for such, even at times when preventive measures were completely unknown. Attributes encoded in different mutations do not add arithmetically. If one virus has a trait that allows it to spread fast and another to evade immunity, these two qualities will not necessarily be pronounced, to the same extent, in a third virus endowed with both mutations. Fear-mongering concerning doomsday viruses is most unlikely to persist.
Herd immunity and Delta variant
When the percentage of subjects acquiring immunity (either by vaccination or contracting the illness) exceeds a threshold, epidemics wane and disappear. The point at which this transpires depends on the value of the basic reproduction number R0; determined on the assumption there were no immune individuals, at the time the pathogen initiated the epidemic. As the immunity of the community increases, the reproduction number decreases proportionate to the fraction of people remaining susceptible and the rate of transmission is determined by an effective reproduction number RE. If N is the total population and M the number among them immune, the fraction susceptible is 1- M/N. Therefore the reproduction number reduces to the effective value RE = R0 (1 – M/N). Once RE reaches a value less than unity, the epidemic ceases to continue and the threshold corresponding to RE = 1, occurs when M/N = 1 -1/R0. At the beginning of the pandemic, the value of R0 was approximately 2.5 and the above formula yields M/N = 0.6, so that herd immunity threshold is 60 percent. For the highly transmissible Delta variant, a mean value of R0 is 7.5 and the same formula gives a herd immunity threshold of 87 percent. As vaccinated persons sometimes get re-infected, the actual threshold may exceed the above number, suggesting herd immunity is virtually beyond reach. Fortunately, R0 can be reduced by preventive measures such as social distancing, wearing masks and hand sanitization, thereby lowering the threshold.
Are we sufficiently disciplined to follow preventive measures stringently? The virus will continue to evolve via random mutations and their selection may be influenced by our behaviour. Will it turn more deadly or less deadly? These questions are too complex and unpredictable.
Fortunately, vaccines answer satisfactorily and redesigning and improvements are within reach. Preventive measures dampen transmission significantly. Every individual needs to follow these two strategies confidently, without resorting to unproven practices and myth.
Features
The silent crisis: A humanitarian plea for Sri Lankan healthcare
As a clinician whose journey in medicine began from the lecture halls of the Colombo Medical Faculty, in 1965, and then matured through securing the coveted MBBS(Ceylon) degree in 1970, followed by a further kaleidoscopic journey down the specialist corridors, from 1978 onwards, I have witnessed the remarkable evolution of healthcare in Sri Lanka. I have seen the admirable resolve of a nation that managed to offer free healthcare, at the point of delivery, to all its citizens, and I have seen many a battle being fought to bring state-of-the-art treatments for the benefit of sick patients, even despite some of the initial scepticism on the part of some.
However, as we now try to navigate the turbulent waters of 2026, I find myself compelled to speak even impulsively. This is not a mission of fault-finding, or a manifestation of a desire to “ruffle feathers,” for the sake of fanning a fire. Rather, it is a reflection offered in good faith, born from the “Spirit of an Enthusiast” who has seen both the brickbats as well as the accolades bestowed on our profession. My goal is relatively simple: which is to bring to light the silent, sometimes extremely difficult, situations faced by patients, doctors, and relatives, and to urge for a compassionate and collective solution to a crisis that threatens the very foundation of the care we provide.
The Generic Gamble: The Lament of the Ward
The cornerstone of our health service has always been the provision of free medicine to all who come to our state medical facilities. For decades, the “generic-only” policy served as a vital safety net. But, today, that net is fraying, not just at the edges but virtually as a whole. In our hospital wards, the clinician’s heart sinks when a patient fails to respond to a standard course of treatment.
We are increasingly haunted by the fancy terminology, “Quality Failure”, as alerts on medicinal drugs. When an anti-infective medicine lacks the potency to clear an infection, or when a poor-quality generic drug fails to stabilise the circulation of a little gasping child who is fighting for his life, the treating doctor is left in a state of agonising clinical despair. It is a profound lament to realise that while the medicine is “available” on the shelf, its efficacy remains as a question mark. The “free health service” becomes tragically and obstinately expensive when it leads to prolonged hospital stays, complications, or, in the worst cases, even the loss of a life that could have been saved with a more reliable formulation of an essential medicine. We must acknowledge that a cheap drug that does not work is the most expensive drug of all. For the doctor, this turns every prescription into a calculated risk, a far cry from the “best possible care” we were trained to deliver. These situations are certainly not the whims of fancy of a wandering mind, but real-time occurrences in our health service.
The Vanishing Innovators and the Small Market Reality
In the private sector, the situation is equally dire, though the causes are different. We must face a hard truth: Sri Lanka is a comparatively small market in the global pharmaceutical landscape. For the world’s leading manufacturers of proven, branded medicines and vaccines, our island is often a small, rather peripheral, consideration.
When the National Medicines Regulatory Authority (NMRA) fixes prices at levels that do not even cover the “Cost, Insurance, and Freight” (CIF) value, let alone the massive research and development costs of these innovator drugs, these companies inevitably reach a breaking point. They do not “bail out” through a lack of compassion, but do so even reluctantly sometimes, because they simply cannot sustain their operations at a loss.
Over the last few years, we have watched in silence as reputable international companies have closed their shops and departed our shores. With them have gone some of the vaccines that provided a lifetime of immunity, and the so-called branded drugs that offered predictable, life-saving results. When these “Gold Standards” vanish, the void is often filled by products from regions with lower regulatory oversight, leaving the patient with no choice but to settle for what is available or just what is left.
The Shadow Economy of “Baggage Medicines”
Perhaps the most heartbreaking symptom of this broken system is the rise of the “baggage medicine” market. Walk into any major private hospital today, and you will hear the whispered conversations of relatives trying to source drugs from abroad, in a clandestine manner.
Reputed branded drugs are being brought into the country in the suitcases of international travellers. While these relatives are acting out of pure, desperate love, the medical risks are astronomical. These medicines sometimes bypass the essential “Cold Chain” requirements for temperature-sensitive products like insulin or specialised vaccines. There is no way to verify if the drug in the suitcase is genuinely effective, or if it has been rendered inert by the heat of a cargo hold of an aircraft.
As a physician, it is an agonising dilemma: do I administer a drug brought in a suitcase to save a life, knowing very well that I cannot certify its safety? We are forcing our citizens into a shadow economy of survival, stripped of the protections a modern regulatory body should provide.
The Unavoidable Storm: Geopolitical Shocks
Adding to this internal struggle is the current unrest in the Middle East. As of March 2026, the escalation of conflict has sent shockwaves through global supply chains. With major maritime routes, like the Strait of Hormuz effectively halted and air cargo capacity from Middle Eastern hubs, like Dubai, slashed by over 50%, the cost of transporting medicine has become a moving target.
* Skyrocketing Logistics: Freight surcharges and war-risk insurance premiums have added “unavoidable costs” that simply cannot be absorbed by local importers under a rigid price cap.
* Delayed Transport is delayed healing:
Shipments rerouted around the Cape of Good Hope add weeks to delivery times, leading to stockouts of even the most basic medical consumables.
These are global forces beyond our control, but our regulatory response must be agile enough to recognise them. If we ignore these external costs, we are not just controlling prices; we are ensuring that the medicine never arrives at all.
The Rights of Patients Seeking Private Healthcare
Whatever the reason for patients seeking private healthcare, all of us have an abiding duty to respect their wishes. It is their unquestionable right to have access to drugs and vaccines of proven high quality, if they decide to go into Private Fee-levying Healthcare. This is particularly relevant to the immunisation of children. Sometimes the child receives the first dose of a given vaccine in a Private Hospital, but when he or she is taken for the second dose, that particular vaccine is not available, and they are not able to tell the parents when it would be available as well.
Some of the abiding problems, associated with immunisation of children and adults in the Private Sector, were graphically outlined at the Annual General Meeting of the Vaccines and Infectious Diseases Forum of Sri Lanka, held on the 10th of March, 2026. This needs to be attended to as a significant proportion of vaccines are administered to patients, both children and adults, in the Private Sector.
In other cases, the drug or drugs of proven quality is or are not available in the Private Sector as the company, or importing authority, has wound up the operations in our country due to their inability to sustain the operations, resulting from factors entirely beyond their control. Let us face it, the current pharmaceutical industry is significantly profit-oriented, and they will continue to operate only in countries where their profit margins are quite lucrative.
A Humane Call to All Stakeholders
The current scenario is a shared burden, and it requires a shared, compassionate solution. We must look at this, not through the lens of policy or profit, but through the eyes of the patient waiting in the clinic or in the ward.
* To the Ministry of Health and the NMRA:
We recognise the extremely difficult task of balancing affordability with quality. However, we urge a “Middle Path.” We need a dynamic pricing mechanism that reflects the reality of global trade logistics and the unique challenges of a relatively smaller market. Let us prioritise the restoration of “Quality Assurance” as the primary mandate, ensuring that every generic drug in the state sector is as reliable as the branded ones we have lost. To be able to provide such an abiding certificate of good quality, we need a fully-equipped state-of-the-art laboratory.
* To the Private Sector and Importers:
We ask you to remain committed to the people of Sri Lanka. Your role is not just commercial; it is a vital part of the national health infrastructure. A transparent dialogue with the regulator is essential to prevent more companies from leaving.
* To our Patients and their Families:
We hear your lamentations. We see the struggle in your eyes when a drug is unavailable or when you are forced to seek alternatives from abroad. We respect your right to seek the best possible treatment, and we are advocating for a system that honours that choice legally and safely.
Finally, the Spirit of Care
In the twilight of my career, I look back at my work and the thousands of patients I have treated. The “Spirit of an Enthusiast” is certainly not one of resignation, but of persistent hope. We have the clinical talent and the commitment of our healthcare professionals, we have the history of a strong health service, and we have a populace that deserves the best. For us, in this beautiful land, hope springs eternal.
Let us stop the “baggage medicine” culture. Let us invite the innovators back to our shores by treating them as partners in health, not just as vendors. Let us also ensure that our state-sector generics are beyond reproach.
This is a mission to find a way forward. For the sake of the child in the ward, the elderly patient in the clinic, and the integrity of the medical profession. We desperately need to act now, together, hand in hand, and with a pulsating heart of concern, for the entire humanity we are committed to serve.
by Dr B. J. C. Perera
MBBS(Cey), DCH(Cey), DCH(Eng), MD(Paediatrics), MRCP(UK), FRCP(Edin),
FRCP(Lond), FRCPCH(UK), FSLCPaed, FCCP, Hony. FRCPCH(UK), Hony. FCGP(SL)
Specialist Consultant Paediatrician and Honorary Senior Fellow,
Postgraduate Institute of Medicine, University of Colombo, Sri Lanka.
Features
Social and political aspects of Buddhism in a colonial context
I was recently given several books dealing with religion, and, instead of looking at questions of church union in current times, I turned first to Buddhism in the 19th century. Called Locations of Buddhism: Colonialism and Modernity in Sri Lanka, the book is a study by an American scholar, Anne M Blackburn, about developments in Buddhism during colonial rule. It focuses on the contribution of Ven. Hikkaduwe Sri Sumangala who was perhaps the most venerated monk in the latter part of the 19th century.
Hikkaduwe, as she calls Ven. Sumangala through the book, is best known as the founder of the Vidyodaya Pirivena, which was elevated to university statues in the fifties of this century, and renamed the University of Sri Jayewardenepura in the seventies. My work in the few years I was there was in the Sumangala Building, though I knew little about the learned monk who gave it its name.
He is also renowned for having participated in the Panadura debates against Christians, and having contributed to the comparative success of the Buddhist cause. It is said that Colonel Olcott came to Sri Lanka after having read a report of one of the debates, and, over the years, Ven. Sumangala collaborated with him, in particular with regard to the development of secondary schools. At the same time, he was wary of Olcott’s gung ho approach, as later he was wary of the Anagarika Dharmapala, who had no fear of rousing controversy, his own approach being moderate and conciliatory.
While he understood the need for a modern education for Buddhist youngsters, which Olcott promoted, free of possible influences to convert which the Christian schools exercised, he was also deeply concerned with preserving traditional learning. Thus, he ensured that in the pirivena subjects such as astrology and medicine were studied with a focus on established indigenous systems. Blackburn’s account of how he leveraged government funding given the prevailing desire to promote oriental studies while emphatically preserving local values and culture is masterly study of a diplomat dedicated to his patriotic concerns.
He was, indeed, a consummately skilled diplomat in that Blackburn shows very clearly how he satisfied the inclinations of the laymen who were able to fund his various initiatives. He managed to work with both laymen and monks of different castes, despite the caste rivalry that could become intense at times. At the same time, he made no bones about his own commitment to the primacy of the Goigama caste, and the exclusiveness of the Malwatte and Asgiriya Chapters.
What I knew nothing at all about was his deep commitment to internationalism, and his efforts to promote collaboration between Ceylon Lanka and the Theravada countries of South East Asia. One reason for this was that he felt the need for an authoritative leader, which Ceylon had lost when its monarchy was abolished by the British. Someone who could moderate disputes amongst monks, as to both doctrine and practice, seemed to him essential in a context in which there were multiple dispute in Ceylon.
Given that Britain got rid of the Burmese monarchy and France emasculated the Cambodian one, with both of which he also maintained contacts, it was Thailand to which he turned, and there are records of close links with both the Thai priesthood and the monarchy. But in the end the Thai King felt there was no point in taking on the British, so that effort did not succeed.
That the Thai King, the famous Chulalongkorn, did not respond positively to the pleas from Ceylon may well have been because of his desire not to tread on British toes, at a time when Thailand preserved its independence, the only country in Asia to do so without overwhelming British interventions, as happened for instance in Nepal and Afghanistan, which also preserved their own monarchies. But it could also have been connected with the snub he was subject to when he visited the Temple of the Tooth, and was not permitted to touch the Tooth Relic, which he knew had been permitted to others.
The casket was taken away when he leaned towards it by the nobleman in charge, a Panabokke, who was not the Diyawadana Nilame of the day. He may have been entrusted with dealing with the King, as a tough customer. Blackburn suggests it is possible the snub was carefully thought out, since the Kandyan nobility had no fondness for the low country intercourse with foreign royalty, which seemed designed to take away from their own primacy with regard to Buddhism. The fact that they continued subservient to the British was of no consequence to them, since they had a façade of authority.
The detailed account of this disappointment should not, however, take away from Ven. Sumangala’s achievement, and his primacy in the country following his being chosen as the Chief Priest for Adam’s Peak, at the age of 37, which placed him in every sense at the pinnacle of Buddhism in Ceylon. Blackburn makes very clear the enormous respect in which he was held, partly arising from his efforts to order ancient documents pertaining to the rules for the Sangha, and ensure they were followed, and makes clear his dominant position for several decades, and that it was well deserved.
by Prof. Rajiva Wijesinha
Features
Achievements of the Hunduwa!
Attempting to bask in the glory of the past serves no purpose, some may argue supporting the contention of modern educationists who are advocating against the compulsory teaching of history to our youth. Even the history they want to teach, apparently, is more to do with the formation of the earth than the achievements of our ancestors! Ruminating over the thought-provoking editorial “From ‘Granary of the East’ to a mere hunduwa” (The Island, 5th March), I wished I was taught more of our history in my schooldays. In fact, I have been spending most of my spare time watching, on YouTube, the excellent series “Unlimited History”, conducted by Nuwan Jude Liyanage, wherein Prof. Raj Somadeva challenges some of the long-held beliefs, based on archaeological findings, whilst emphasising on the great achievements of the past.
Surely, this little drop in the Indian ocean performed well beyond its size to have gained international recognition way back in history. Pliny the Elder, the first-century Roman historian, therefore, represented Ceylon larger than it is, in his map of the world. Clicking on (https://awmc.unc.edu/2025/02/10/interactive-map-the-geography-of-pliny-the-elder/) “Interactive Map: The Geography of Pliny the Elder” in the website of the Ancient World Mapping Centre at the University of North Carolina at Chappel Hill, this is the reference to Anuradhapura, our first capital:
“The ancient capital of Sri Lanka from the fourth century BCE to the 11th century CE. It was recorded under the name Anourogrammon by Ptolemy, who notes its primary political status (Basileion). It has sometimes been argued that a “Palaesimundum” mentioned by Pliny in retelling the story of a Sri Lankan Embassy to the emperor Claudius is also to be identified with Anourogrammon. A large number of numismatic finds from many periods have been reported in the vicinity.”
Ptolemy, referred to above, is the mathematician and astronomer of Greek descent born in Alexandria, Egypt, around 100 CE, who was well known for his geocentric model of the universe, till it was disproved 15 centuries later, by Copernicus with his heliocentric model.
It is no surprise that Anuradhapura deservedly got early international recognition as Ruwanwelisaya, built by King Dutugemunu in 140 BCE, was the seventh tallest building in the ancient world, perhaps, being second only to the Great Pyramids of Giza, at the time of construction. It was overtaken by Jetawanaramaya, built by King Mahasena around 301 CE, which became the third tallest building in the ancient world and still holds the record for the largest Stupa ever built, rising to a height of 400 feet and made using 93.3 million baked mud bricks. Justin Calderon, writing for CNN travel under the heading “The massive megastructure built for eternity and still standing 1,700 years later” (https://edition.cnn.com/travel/jetavanaramaya-sri-lanka-megastructure-anuradhapura) concludes his very informative piece as follows:
“Jetavanaramaya stands today as evidence of an ancient society capable of organising labour, materials and engineering knowledge on a scale that rivalled any civilisation of its time.
That it remains relatively unknown beyond Sri Lanka may be one of history’s great oversights — a reminder that some of the ancient world’s most extraordinary achievements were not carved in stone, but shaped from earth, devotion and human ingenuity.”
Extraordinary achievements of our ancestors are not limited to Stupas alone. As mentioned in the said editorial, our country was once the Granary of the East though our present leader equated it to the smallest measure of rice! Our canal systems with the gradient of an inch over a mile stand testimony to engineering ingenuity of our ancestors. When modern engineers designed the sluice gate of Maduru Oya, they were pleasantly surprised to find the ancient sluice gates designed by our ancestors, without all their technical knowhow, in the identical spot.
Coming to modern times, though we vilify J. R. Jayewardene for some of his misdeeds later in his political career, he should be credited with changing world history with his famous speech advocating non-violence and forgiveness, quoting the words of the Buddha, at the San Francisco Conference in 1945. Japan is eternally grateful for the part JR played in readmitting Japan to the international community, gifting Rupavahini and Sri Jayewardenepura Hospital. Although we have forgotten the good JR did, there is a red marble monument in the gardens of the Great Buddha (Daibutsu) in Kamakura, Japan with Buddha’s words and JR’s signature.
It cannot be forgotten that we are the only country in the world that was able to comprehensively defeat a terrorist group, which many experts opined were invincible. Services rendered by the Rajapaksa brothers, Mahinda and Gotabaya, should be honoured though they are much reviled now, for their subsequent political misdeeds. Though Gen-Z and the following obviously have no recollections, it is still fresh in the minds of the older generation the trauma we went through.
It is to the credit of the democratic process we uphold, that the other terrorist group that heaped so much of misery on the populace and did immense damage to the infrastructure, is today in government.
As mentioned in the editorial, it is because Lee Kuan Yew did not have a ‘hundu’ mentality that Singapore is what it is today. He once famously said that he wanted to make a Ceylon out of Singapore!
Let our children learn the glories of our past and be proud to be Sri Lankan. Then only they can become productive citizens who work towards a better future. Resilience is in our genes and let us facilitate our youth to be confident, so that they may prove our politicians wrong; ours may be a small country but we are not ‘hundu’!
By Dr Upul Wijayawardhana
-
News7 days agoProf. Dunusinghe warns Lanka at serious risk due to ME war
-
News5 days agoHistoric address by BASL President at the Supreme Court of India
-
Business6 days agoBOI launches ‘Invest in Sri Lanka’ forum
-
Sports6 days agoRoyal start favourites in historic Battle of the Blues
-
Sports5 days agoThe 147th Royal–Thomian and 175 Years of the School by the Sea
-
News6 days agoCEBEU warns of operational disruptions amid uncertainty over CEB restructuring
-
Features6 days agoIndian Ocean zone of peace torpedoed!
-
News5 days agoPower sector reforms jolted by 40% pay hike demand
